Laura R Loehr1, Elsayed Z Soliman2, Anna K Poon3, David Couper3, Lin Yee Chen4, Thomas H Mosley5, Lynne E Wagenknecht2, Eric A Whitsel3, Alvaro Alonso6, Lisa Wruck7, Gerardo Heiss3. 1. University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: Loehr@unc.edu. 2. Wake Forest University School of Medicine, Winston Salem, NC. 3. University of North Carolina at Chapel Hill, Chapel Hill, NC. 4. University of Minnesota, Minneapolis, MN. 5. University of Mississippi Medical Center, Jackson, MS. 6. Emory University, Atlanta, GA. 7. Duke Clinical Research Institute, Durham, NC.
Abstract
BACKGROUND: A lower prevalence of atrial fibrillation (AF), but paradoxically higher burden of cardiovascular disease risk factors, has been observed among African Americans compared to Whites in studies of AF identified by mostly 12-lead electrocardiograms (ECGs) and clinically. METHODS: We performed 48-hour ambulatory electrocardiography (aECG) in a biracial sample of 1,193 participants in the Atherosclerosis Risk in Communities (ARIC) (mean age = 78 years, 62% African Americans, 64% female). Atrial fibrillation was identified from aECG, study visit ECGs, and discharge codes from cohort hospitalizations. We used covariate-adjusted logistic regression to estimate prevalence odds ratios (ORs) for AF in African Americans versus Whites, with adjustment for sampling and nonresponse. RESULTS: African Americans were more likely than Whites to have hypertension and diabetes but less likely to have coronary heart disease. The prevalence of AF detected by aECG or ARIC study ECG (adjusted for age and coronary heart disease) was lower in African Americans than Whites (2.7% vs 5.0%). White men had a higher (although not significant) AF prevalence of 7.8% compared to the other race and gender groups at 2.3%-2.8%. The adjusted OR for AF was 0.49 (0.24-0.99) comparing African Americans to Whites. Findings were similar when AF was defined to include prior AF hospitalizations (OR = 0.42, 0.25-0.72). There were no significant differences by race for asymptomatic or paroxysmal AF. CONCLUSIONS: Atrial fibrillation was less prevalent in African American than white older adults, regardless of detection method. Although overall detection of new AF cases with aECG was low, future studies should consider longer-term monitoring to characterize AF by race.
BACKGROUND: A lower prevalence of atrial fibrillation (AF), but paradoxically higher burden of cardiovascular disease risk factors, has been observed among African Americans compared to Whites in studies of AF identified by mostly 12-lead electrocardiograms (ECGs) and clinically. METHODS: We performed 48-hour ambulatory electrocardiography (aECG) in a biracial sample of 1,193 participants in the Atherosclerosis Risk in Communities (ARIC) (mean age = 78 years, 62% African Americans, 64% female). Atrial fibrillation was identified from aECG, study visit ECGs, and discharge codes from cohort hospitalizations. We used covariate-adjusted logistic regression to estimate prevalence odds ratios (ORs) for AF in African Americans versus Whites, with adjustment for sampling and nonresponse. RESULTS: African Americans were more likely than Whites to have hypertension and diabetes but less likely to have coronary heart disease. The prevalence of AF detected by aECG or ARIC study ECG (adjusted for age and coronary heart disease) was lower in African Americans than Whites (2.7% vs 5.0%). White men had a higher (although not significant) AF prevalence of 7.8% compared to the other race and gender groups at 2.3%-2.8%. The adjusted OR for AF was 0.49 (0.24-0.99) comparing African Americans to Whites. Findings were similar when AF was defined to include prior AF hospitalizations (OR = 0.42, 0.25-0.72). There were no significant differences by race for asymptomatic or paroxysmal AF. CONCLUSIONS: Atrial fibrillation was less prevalent in African American than white older adults, regardless of detection method. Although overall detection of new AF cases with aECG was low, future studies should consider longer-term monitoring to characterize AF by race.
Authors: Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert Journal: Circulation Date: 2010-11-16 Impact factor: 29.690
Authors: Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso Journal: Circulation Date: 2015-04-27 Impact factor: 29.690
Authors: Chu-Pak Lau; T David Gbadebo; Stuart J Connolly; Isabelle C Van Gelder; Alessandro Capucci; Michael R Gold; Carsten W Israel; Carlos A Morillo; Chung-Wah Siu; Haruhiko Abe; Mark Carlson; Hung-Fat Tse; Stefan H Hohnloser; Jeff S Healey Journal: J Cardiovasc Electrophysiol Date: 2013-01-28
Authors: Fatima Rodriguez; Marcia L Stefanick; Philip Greenland; Elsayed Z Soliman; JoAnn E Manson; Nisha Parikh; Lisa W Martin; Joseph C Larson; Mark Hlatky; Rami Nassir; Crystal W Cené; Beatriz L Rodriguez; Christine Albert; Marco V Perez Journal: Am Heart J Date: 2016-03-17 Impact factor: 4.749
Authors: Carlo Mannina; Zhezhen Jin; Kenji Matsumoto; Kazato Ito; Angelo Biviano; Mitchell S V Elkind; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Int J Cardiol Date: 2021-05-06 Impact factor: 4.039
Authors: Alvaro Alonso; Aniqa B Alam; Hooman Kamel; Vignesh Subbian; Jun Qian; Eric Boerwinkle; Mine Cicek; Cheryl R Clark; Elizabeth G Cohn; Kelly A Gebo; Roxana Loperena-Cortes; Kelsey R Mayo; Stephen Mockrin; Lucila Ohno-Machado; Sheri D Schully; Andrea H Ramirez; Philip Greenland Journal: PLoS One Date: 2022-03-16 Impact factor: 3.752
Authors: Angela Sivly; Haeshik S Gorr; Derek Gravholt; Megan E Branda; Mark Linzer; Peter Noseworthy; Ian Hargraves; Marleen Kunneman; Chyke A Doubeni; Takeki Suzuki; Juan P Brito; Elizabeth A Jackson; Bruce Burnett; Mike Wambua; Victor M Montori Journal: BMC Health Serv Res Date: 2022-08-12 Impact factor: 2.908
Authors: Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani Journal: Nat Rev Cardiol Date: 2021-06-02 Impact factor: 32.419
Authors: Jacqueline D Wright; Aaron R Folsom; Josef Coresh; A Richey Sharrett; David Couper; Lynne E Wagenknecht; Thomas H Mosley; Christie M Ballantyne; Eric A Boerwinkle; Wayne D Rosamond; Gerardo Heiss Journal: J Am Coll Cardiol Date: 2021-06-15 Impact factor: 27.203
Authors: Anna K Poon; Eric A Whitsel; Gerardo Heiss; Elsayed Z Soliman; Lynne E Wagenknecht; Takeki Suzuki; Laura Loehr Journal: BMC Cardiovasc Disord Date: 2020-05-11 Impact factor: 2.298